Today: 8 February 2026
Subscribe

Electric Air Taxis Take Flight: Beta Technologies’ $1 Billion IPO Ignites the Electric Aviation Revolution

Electric Air Taxis Take Flight: Beta Technologies’ $1 Billion IPO Ignites the Electric Aviation Revolution

Beta Technologies’ Blockbuster IPO Debut Beta Technologies officially hit Wall Street on November 4, 2025, ringing the NYSE opening bell to celebrate its public debutsevendaysvt.com. The company’s IPO priced at $34 per share, above the marketed range of $27–33reuters.com, which reflects strong investor demand. In fact, Beta upsized the offering from 25 million to 29.85 million Class A shares (with underwriters granted an option for ~4.48 million more)businesswire.combusinesswire.com. This netted about $1.01–1.02 billion in fresh capital for the company, overshooting initial expectations of ~$825 milliontechbuzz.ai. At the IPO price, Beta’s market capitalization comes out around $7.4–7.5 billionreuters.comsevendaysvt.com. The enthusiastic reception marks a milestone not just for Beta but
4 November 2025
·
Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

Company Overview: Telehealth for High-Acuity Care VSee Health, Inc. is a Silicon Valley-founded telehealth technology and services provider specializing in high-acuity virtual care. Founded in 2008 by Dr. Milton Chen, VSee built a secure video telemedicine platform so robust it was even utilized by NASA for astronaut healthcarebusinesswire.com. Today, after merging with iDoc Telehealth via a SPAC deal in mid-2024, VSee offers an integrated suite of telehealth solutions for hospitals and health systems. The company’s headquarters are in Massachusetts, and it has ~154 employees as of 2025finviz.com. Business Model: VSee’s platform combines telehealth software with physician services to enable things
4 November 2025
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Background: Novo vs. Pfizer in the Weight-Loss Drug Race The fight for Metsera is driven by fierce competition in GLP-1 obesity drugs. Novo Nordisk is the maker of Wegovy/Ozempic, and Eli Lilly’s drugs recently overtook Wegovy in US market sharereuters.com. Novo’s new CEO Mike Doustdar and the company’s controlling foundation have pushed for bolder moves after days of sliding market performancereuters.comreuters.com. In late October, Novo – which had already agreed a separate $5 billion deal to buy diabetes biotech Akero – suddenly “launched a bid…valuing [Metsera] at some $9 billion and crashing Pfizer’s deal”reuters.com. This was weeks after Novo’s top shareholder
4 November 2025
·
Netflix Rumors Send iHeartMedia Stock Soaring – A Deep Dive into IHRT’s 2025 Outlook

Netflix Rumors Send iHeartMedia Stock Soaring – A Deep Dive into IHRT’s 2025 Outlook

Below, we dive into each of these aspects in detail – from the latest stock pop on Netflix rumors to iHeart’s earnings trends, debt refinancing efforts, expert opinions, and how IHRT stacks up against competitors in the evolving media landscape. IHRT Stock Price & Market Performance (Nov 2025) iHeartMedia’s stock has been on a rollercoaster. At the start of 2025, IHRT was languishing near ~$1 per share amid recession fears and industry pessimism. Over the summer, modestly improved results and debt extensions helped shares recover into the $2–3 range. As of November 4, 2025, IHRT has surged to multi-month highs,
4 November 2025
·
Global Payments (GPN) Surges on Earnings Beat and Transformation – What’s Next for This Fintech Powerhouse?

Global Payments (GPN) Surges on Earnings Beat and Transformation – What’s Next for This Fintech Powerhouse?

Company Overview Global Payments Inc. (NYSE: GPN) is a leading worldwide provider of payment technology and software solutions for merchants, issuers, and developers. The company enables businesses to process card, digital and contactless payments, as well as related services like payment security, analytics, and point-of-sale softwaremarkets.ft.combusinessmodelanalyst.com. Headquartered in Atlanta, Georgia, Global Payments has about 27,000 employees in 38 countries and is a member of the Fortune 500 and S&P 500 indicesmarkets.ft.com. Traditionally, Global Payments operated through two segments: Merchant Solutions (payment processing and services for merchants of all sizes) and Issuer Solutions (card issuing and account services for financial institutions).
4 November 2025
···
Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Diverging Markets: Tech Strength vs. Blue-Chip Weakness Stock trading to kick off November has been a tale of two markets. High-tech and growth stocks are extending their momentum, while old-line blue chips struggle. On Monday (Nov. 3), the benchmark S&P 500 and Nasdaq Composite managed to close higher – up 0.17% and 0.46%, respectively – even as the Dow Jones Industrial Average fell nearly half a percentreuters.com. This split reflects the radically different fortunes of tech-focused firms versus more traditional industries. What’s driving the divergence? In large part, blockbuster tech news gave the Nasdaq a boost. E-commerce and cloud titan
4 November 2025
·
Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz’s Q3 2025 Comeback: First Profit in Years Fuels Rally Cars parked near a Hertz rental location at New York’s JFK Airport (symbolizing recovering demand). Hertz stunned investors with a return to profitability in Q3 2025, marking a pivotal milestone in its post-bankruptcy turnaround. Hertz Global Holdings’ latest earnings report proved to be a game-changer for the stock. On November 4, 2025, the company announced that it had swung to a net profit for the first time in roughly two years – a stark turnaround from the steep losses logged throughout 2024gurufocus.com. The third-quarter 2025 net income of $184 million
4 November 2025
·
Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Current Stock Price & Recent Performance Dave Inc.’s stock has been on a tear in 2025. Shares currently trade around $264 as of November 4, 2025, after spiking nearly 10% on the morning of its earnings releasestockanalysis.com. This jump extended an already strong uptrend – DAVE has rallied over 500% in the past 12 monthsfinviz.com, making it one of the market’s top performers (outperforming ~98.5% of all stocks)chartmill.com. By contrast, the S&P 500 is up only ~18% in the same period. DAVE’s meteoric rise has come after a prolonged slump in 2022–2023; the stock hit a low near $6 (pre-reverse-split)
4 November 2025
·
Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Company Profile & Background Scienture Holdings, Inc. is a tiny specialty pharmaceutical company focused on developing and commercializing novel formulations that address unmet needs in healthcare Globenewswire Globenewswire. The company’s roots trace back to a 2024 merger with TRxADE Health, a drug marketplace business – after which the combined entity rebranded as Scienture (NASDAQ: SCNX) Nasdaq. In early 2025, management decisively pivoted to pharma: selling off legacy pharmacy/IT subsidiaries for $5 million to free up resources and “dedicate full focus” to its specialty drug pipeline Globenewswire Globenewswire. Today Scienture is headquartered in Tampa, FL (with R&D operations in New York)
4 November 2025
·
Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

A Wild Week for PRLD Stock Prelude Therapeutics – a small precision oncology biotech – suddenly became one of the market’s most volatile stocks in early November 2025. On Monday, Nov 3, PRLD shares skyrocketed, at one point gaining over 150%. The stock surged from roughly $1.60 into the $3–4 range, fueled by speculative buzz and unusually heavy tradingrttnews.com. More than 29 million shares changed hands in a single day (versus an average of ~250,000), and the price hit a 52-week high of $4.19rttnews.com. By the session’s end, Prelude closed near $4 – an astronomical one-day move for a company
4 November 2025
··
Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Current Stock Price & Recent Performance Chart: ONDS daily closing price, Sep–Nov 2025. After a meteoric rise in early October, the stock has retraced to the mid-$6 range. Ondas Holdings’ stock has experienced a roller coaster ride in recent weeks. After trading around $7 in late September, ONDS exploded to a 52-week high near $11.26 by October 8, 2025stockinvest.us. This ~60% surge in a week was accompanied by record volume (over 100 million shares traded on Oct 2) amid breaking news on acquisitions and funding. The rally quickly reversed course: by November 3, ONDS closed at $6.15, down ~45% from
4 November 2025
Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Recent News Highlights (Early November 2025) Cipher Mining has made headlines this week with a flurry of major developments: Company Overview & Business Model Cipher Mining Inc. is a U.S.-based technology company that builds and operates industrial-scale data centers for Bitcoin mining and high-performance computing (HPC) hostinginsidermonkey.com. Formed in 2021 as a spin-off of Dutch mining hardware maker Bitfury, Cipher went public via a SPAC merger (valued around $2 billion at the time)datacenterdynamics.com. Headquartered in New York, the company’s core business has been Bitcoin mining – using powerful computer rigs in large data centers to secure the Bitcoin network in exchange
4 November 2025
···
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven careen.wikipedia.org. As a spin-off, Kenvue took over J&J’s well-known retail brands, ranging from over-the-counter (OTC) medicines to skincare and baby care. Today its portfolio spans three segmentsinvesting.com: Formally incorporated in 2022, Kenvue began trading on the NYSE (ticker KVUE) in May 2023 after a highly anticipated IPOen.wikipedia.org. The IPO raised $3.8 billion – the largest U.S. listing in nearly two years – and initially valued Kenvue
4 November 2025
·
Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bottom Line: Bitfarms has rapidly transformed in 2025 from a struggling miner into a well-capitalized player at the forefront of both Bitcoin mining and emerging AI infrastructure. The stock’s dramatic rise mirrors the company’s improved prospects, but future performance will depend on balancing its core crypto business with its new growth ventures. In the near term, all eyes are on the Q3 2025 earnings (due Nov 13) and whether Bitfarms can meet lofty expectations amid Bitcoin’s rally. Longer term, if Bitcoin remains strong and Bitfarms executes its U.S. expansion, the company could transition into a hybrid mining–HPC powerhouse. Investors bullish
4 November 2025
·
Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

NVDA Stock Skyrockets on AI Frenzy Nvidia’s stock has been on a meteoric rise, fueled by an unprecedented boom in artificial intelligence. As of November 4, 2025, NVDA trades around $207 per share, up roughly 70–80% year-to-dateeconomictimes.indiatimes.comeconomictimes.indiatimes.com. The stock recently notched all-time highs, propelling Nvidia’s market capitalization above $5 trillion for the first timeeconomictimes.indiatimes.com. This milestone, reached on October 29, 2025, made Nvidia the first publicly traded company ever to cross the $5 trillion markeconomictimes.indiatimes.com – ahead of tech giants like Apple and Microsoft. Shares surged ~3% that day to $206.08 on nearly 190 million shares traded, reflecting fervent investor confidence in Nvidia’s
4 November 2025
···
Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Stock Price and Recent Performance Year-to-date chart of Evoke Pharma (EVOK) stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement (right end of chart) triggered a dramatic spike to new highs, bringing the stock roughly back to breakeven for the yeartipranks.com. Evoke Pharma’s stock has experienced extreme volatility in recent weeks. After trading in the mid-$4 to $5 range through October, EVOK plunged 10.9% on November 3, 2025 to $4.59 at the closetipranks.com. The very next day, news of the buyout sent the stock exploding upward – EVOK opened around $10.70 on Nov 4
4 November 2025
·
Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Company Overview & 2025 Developments Zoetis is the global frontrunner in animal health, offering a diverse portfolio for both companion animals (pets) and farm animals. The company’s products range from vaccines and parasiticides to dermatology treatments and high-tech diagnostics. This breadth has helped Zoetis capture the #1 industry position – in 2023 its $8.5B in sales exceeded the next-largest competitor by over 50%proclinical.comproclinical.com. Zoetis continues to leverage this scale and innovation engine in 2025, focusing on pet care growth while managing challenges in livestock. Recent 2025 highlights: The first half of 2025 saw Zoetis deliver solid growth. In Q1, revenue
4 November 2025
··
Harley-Davidson Stock Roars on Earnings Beat – Is HOG a Buy Heading into 2026?

Harley-Davidson Stock Roars on Earnings Beat – Is HOG a Buy Heading into 2026?

Stock Price and Recent Movement Harley-Davidson’s stock price is currently around $27.5 as of November 4, 2025. This reflects a slight increase after the Q3 earnings release. Prior to the results, HOG shares closed at $26.98 on Oct 31 and $27.11 on Nov 3 Chroniclejournal, essentially flat to modestly higher in the lead-up. The better-than-expected earnings gave the stock a boost of about +1.8% to $27.60 in early trading on Nov 4 Chroniclejournal. This recent bump has lifted HOG off the lower end of its trading range. Over the past 52 weeks, the stock ranged from a low around $20.5
4 November 2025
·
Yum! Brands Stock on the Rise: Earnings Beat, Pizza Hut Shakeup & 2025 Outlook

Yum! Brands Stock on the Rise: Earnings Beat, Pizza Hut Shakeup & 2025 Outlook

Stock Price & Recent Movements Yum! Brands’ stock (NYSE: YUM) has been gradually climbing in late October and early November 2025. The shares closed around $139.4 on November 3stockanalysis.com and then jumped over 2% the next morning after the company’s earnings release, trading near $142 in pre-market on Nov 4marketscreener.com. Investors reacted positively to the latest results and strategic news, pushing YUM off its recent lows. At current levels (~$140), YUM sits roughly midway between its 52-week high of about $163 (reached in July 2025) and its 52-week low near $122marketbeat.com. The stock is up approximately 7–8% year-to-datenasdaq.com, roughly on
4 November 2025
·
Norwegian Cruise Line Stock Plunges Despite Record Quarter – Is NCLH Still Set to Sail High in 2025?

Norwegian Cruise Line Stock Plunges Despite Record Quarter – Is NCLH Still Set to Sail High in 2025?

Stock Price & Recent Performance Norwegian Cruise Line Holdings (NYSE: NCLH) stock is seeing turbulent waters in early November 2025. After a relatively quiet October, shares plunged about 9–10% in pre-market trading on Nov 4 following the Q3 earnings releasechartmill.com. The stock closed at $22.18 on Nov 3, then dropped toward ~$20 by midday Nov 4stockanalysis.com. This sharp one-day move erased several weeks of range-bound trading in the low-$20s. In fact, NCLH had been remarkably stable in recent weeks, hovering between $22 and $23 with low volatilitychartmill.com, before the earnings-induced selloff. Year-to-date, Norwegian’s stock performance lags its cruise peers. Even
4 November 2025
1 … 1,377 1,378 1,379 1,380 1,381 … 1,643

Stock Market Today

AppLovin stock price after Friday jump: what APP investors watch before Feb. 11 earnings

8 February 2026
New York, Feb 8, 2026, 05:04 (EST) — Market closed. AppLovin Corp (APP.O) closed Friday up 8.39% at $406.72. With U.S. markets shut for the weekend, the question into Monday is whether buyers keep showing up — or whether the stock slips back into the software sector’s broader churn. (Reuters) That churn is being driven less by one company and more by the AI money trade. A planned $600 billion artificial intelligence spending push by big tech in 2026 has sharpened nerves around cash flow and who wins when the bill comes due. Andrew Wells, chief investment officer at SanJac
KKR stock rebounds 4% after earnings shock; what investors watch before Monday’s open

KKR stock rebounds 4% after earnings shock; what investors watch before Monday’s open

8 February 2026
KKR shares jumped 4.06% to $103.20 Friday, rebounding from a steep drop the day before as trading volume surged. The firm disclosed a $1.4 billion deal to acquire Arctos and set an April 21 vote on governance changes, including a shift to one-vote-per-share by the end of 2026. Investors remain focused on KKR’s software exposure and loan leverage after an AI-driven selloff hit the sector.
Take-Two stock snaps back Friday — the next dates TTWO traders are watching

Take-Two stock snaps back Friday — the next dates TTWO traders are watching

8 February 2026
Take-Two Interactive shares closed up 1.22% at $195.59 Friday, trading between $189.45 and $198.07 on 3.1 million shares. The company reaffirmed Grand Theft Auto VI’s Nov. 19, 2026 release and raised its fiscal 2026 net bookings outlook to as much as $6.7 billion. The Dow closed above 50,000 for the first time.
Gold.com (GOLD) stock jumps nearly 10% as Tether deal and earnings reshape the week ahead

Gold.com (GOLD) stock jumps nearly 10% as Tether deal and earnings reshape the week ahead

8 February 2026
Gold.com, Inc. shares jumped 9.9% to $55.32 Friday after the company announced a $150 million share sale to Tether at an 11.9% discount, with $125 million closing first and the rest pending regulatory approval. Trading volume more than doubled the average. Gold.com posted Q2 revenue of $6.48 billion and net income of $11.6 million, and completed its Monex acquisition in January.
Go toTop